Comprehensive quality management and regulatory compliance for your device

We maintain a Quality Management System to control the design, development and manufacturing processes for products entering into worldwide markets

This system incorporates appropriate quality gates throughout the design and manufacturing process from supplier selection and qualification, through to final acceptance, device tracking and device maintenance.

Integrated Technologies Ltd is accredited and audited to:

Our quality system additionally incorporates BSEN ISO 14791, BSEN 62304 and BSEN 62366, amongst others, to ensure a fully compliant regulatory framework.

ITL works closely within the appropriate European CE marking directives including:

  • 93/42/EEC Medical Device Directive
  • 98/79/EC In-Vitro Diagnostics Directive
  • 2006/95/EC Low Voltage Directive
  • 2004/108/EC Electromagnetic Compatibility Directive
  • 2011/65/EU RoHS II Directive

Medical device regulatory consultancy

We also offer medical device development and regulatory consultancy, including pre-compliance safety and regulatory assessments, to assist you in your medical device product development project.

We have considerable experience in supporting our customers to achieve American Food & Drug Administration (FDA) 510k and Pre-Market Approvals (PMA).

Our Chinese facility also facilitiates China Food & Drug Administration (CFDA) applications.

Furthermore, we can help you to manage submissions and on-going factory audits for Nationally Recognised Testing Laboratories (NRTLs) including UL, CSA, ETL and MET (for US and Canadian market approval).

You may also like...

News
ITL increases critical instrument production during COVID-19 pandemic

As a global design and manufacturing partner of life-saving medical devices and diagnostic instruments, ITL Group (a G&H company) is an essential link in the healthcare supply chain. ITL is currently manufacturing and delivering instrumentation designed to improve respiratory function and oxygen uptake as part of a ventilator system for patients in critical care including those due to COVID-19, as well as hygiene monitoring devices and rapid diagnostic testing platforms.

Read more >

Resource
COVID-19 & MedTech: How to effectively manage supply chain disruption

It’s impossible to anticipate the arrival of global crises such as COVID-19, but the resulting impact on supply chains is putting added pressure on manufacturers worldwide – but what action can you take to build a more resilient supply chain in a time of crisis?

Read more >

Case Study
Magnasense

From lab based analysis to mobile and disposable ‘point of care testing’ (POCT)

View this case study >